• Diagnosis​ ​Info​ ​and​ ​General​ ​Questions

  Potential DMD Treatment Using Mini-Dystrophin Gene Begins Clinical Trial

  Posted by MD forums Moderator on February 19, 2019 at 8:01 am

  Pfizer, Inc has initiated a Phase 1b clinical trial for its investigational mini-dystrophin gene therapy candidate, PF-06939926, in boys with Duchenne muscular dystrophy (DMD). Click here to read mroe about this potential treatment.

  Would you like us to post updates on this clinical trial as they become available?

  replied 5 years, 2 months ago 1 Member · 0 Replies
• 0 Replies

Log In to Reply